Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: SARCOMA - DRUG THERAPY , . Treffer: 31

2021

Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuehr, T; Kostner, S; Pichler, P; Jaeger, T; Kocher, F; Greil, R; Brodowicz, T Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma : Data of real-world utilization in Austria.
Wien Klin Wochenschr. 2021; 133(1-2):21-25 Doi: 10.1007/s00508-019-01556-1
Web of Science PubMed FullText FullText_MUG

 

2017

Berry, V; Basson, L; Bogart, E; Mir, O; Blay, JY; Italiano, A; Bertucci, F; Chevreau, C; Clisant-Delaine, S; Liegl-Antzager, B; Tresch-Bruneel, E; Wallet, J; Taieb, S; Decoupigny, E; Le Cesne, A; Brodowicz, T; Penel, N REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis.
Cancer. 2017; 123(12):2294-2302 Doi: 10.1002/cncr.30661 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Cuppens, T; Annibali, D; Coosemans, A; Trovik, J; Ter Haar, N; Colas, E; Garcia-Jimenez, A; Van de Vijver, K; Kruitwagen, RP; Brinkhuis, M; Zikan, M; Dundr, P; Huvila, J; Carpén, O; Haybaeck, J; Moinfar, F; Salvesen, HB; Stukan, M; Mestdagh, C; Zweemer, RP; Massuger, LF; Mallmann, MR; Wardelmann, E; Mints, M; Verbist, G; Thomas, D; Gommé, E; Hermans, E; Moerman, P; Bosse, T; Amant, F Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.
Clin Cancer Res. 2017; 23(5):1274-1285 Doi: 10.1158/1078-0432.CCR-16-2149 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ferrari, S; Bielack, SS; Smeland, S; Longhi, A; Egerer, G; Sundby Hall, K; Donati, D; Kevric, M; Brosjö, O; Comandone, A; Werner, M; Monge, O; Palmerini, E; Berdel, WE; Bjerkehagen, B; Paioli, A; Lorenzen, S; Eriksson, M; Gambarotti, M; Tunn, PU; Jebsen, NL; Cesari, M; von Kalle, T; Ferraresi, V; Schwarz, R; Bertulli, R; Kasparek, AK; Grignani, G; Krasniqi, F; Sorg, B; Hecker-Nolting, S; Picci, P; Reichardt, P EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Tumori. 2017; 104(1):30-36 Doi: 10.5301/tj.5000696
Web of Science PubMed FullText FullText_MUG

 

Lohberger, B; Stuendl, N; Leithner, A; Rinner, B; Sauer, S; Kashofer, K; Liegl-Atzwanger, B Establishment of a novel cellular model for myxofibrosarcoma heterogeneity.
Sci Rep. 2017; 7(9):44700-44700 Doi: 10.1038/srep44700 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Mir, O; Brodowicz, T; Italiano, A; Wallet, J; Blay, JY; Bertucci, F; Chevreau, C; Piperno-Neumann, S; Bompas, E; Salas, S; Perrin, C; Delcambre, C; Liegl-Atzwanger, B; Toulmonde, M; Dumont, S; Ray-Coquard, I; Clisant, S; Taieb, S; Guillemet, C; Rios, M; Collard, O; Bozec, L; Cupissol, D; Saada-Bouzid, E; Lemaignan, C; Eisterer, W; Isambert, N; Chaigneau, L; Cesne, AL; Penel, N Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol. 2016; 17(12):1732-1742 Doi: 10.1016/S1470-2045(16)30507-1
Web of Science PubMed FullText FullText_MUG

 

2015

Lohberger, B; Leithner, A; Stuendl, N; Kaltenegger, H; Kullich, W; Steinecker-Frohnwieser, B Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation.
BMC Cancer. 2015; 15(3):891-891 Doi: 10.1186/s12885-015-1915-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Brämswig, K; Ploner, F; Martel, A; Bauernhofer, T; Hilbe, W; Kühr, T; Leitgeb, C; Mlineritsch, B; Petzer, A; Seebacher, V; Stöger, H; Girschikofsky, M; Hochreiner, G; Ressler, S; Romeder, F; Wöll, E; Brodowicz, T Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.
Anticancer Drugs. 2014; 25(7):848-853 Doi: 10.1097/CAD.0000000000000108
Web of Science PubMed FullText FullText_MUG

 

Gilg, MM; Wibmer, C; Andreou, D; Avian, A; Sovinz, P; Maurer-Ertl, W; Tunn, PU; Leithner, A Paley's multiplier method does not accurately predict adult height in children with bone sarcoma.
Clin Orthop Relat Res. 2014; 472(8):2506-2513 Doi: 10.1007/s11999-014-3636-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S; Mentzel, T; Utikal, J; Helmbold, P; Mohr, P; Pföhler, C; Schiller, M; Hauschild, A; Hein, R; Kämpgen, E; Kellner, I; Leverkus, M; Becker, JC; Ströbel, P; Schadendorf, D Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up.
Clin Cancer Res. 2014; 20(2):499-510 Doi: 10.1158/1078-0432.CCR-13-1411 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Ploner, F; Lamm, W; Schur, S; Eisterer, W; Kühr, T; Lindorfer, A; Tinchon, C; Köstler, WJ; Szkandera, J; Brodowicz, T The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS).
J Cancer Res Clin Oncol. 2013; 139(8):1337-1342 Doi: 10.1007/s00432-013-1447-8
Web of Science PubMed FullText FullText_MUG

 

2012

Pirker-Frühauf, UM; Friesenbichler, J; Urban, EC; Obermayer-Pietsch, B; Leithner, A Osteoporosis in Children and Young Adults: A Late Effect After Chemotherapy for Bone Sarcoma.
Clin Orthop Relat Res. 2012; 470(10):2874-2885 Doi: 10.1007/s11999-012-2448-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schlick, K; Aigelsreiter, A; Pichler, M; Reitter, S; Neumeister, P; Hoefler, G; Beham-Schmid, C; Linkesch, W Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases.
Onkologie. 2012; 35(7-8):447-450 Doi: 10.1159/000340066 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2010

Gattenlöhner, S; Jörissen, H; Huhn, M; Vincent, A; Beeson, D; Tzartos, S; Mamalaki, A; Etschmann, B; Muller-Hermelink, HK; Koscielniak, E; Barth, S; Marx, A A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.
J Biomed Biotechnol. 2010; 2010(8):187621-187621 Doi: 10.1155/2010/187621 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Grabellus, F; Sheu, SY; Tötsch, M; Lehmann, N; Kaiser, GM; Jasani, B; Taeger, G; Schmid, KW Overexpression of the drug resistance-associated protein metallothionein does not correlate with response of sarcomas to isolated limb perfusion treatment.
J Surg Oncol. 2010; 101(6):465-470 Doi: 10.1002/jso.21513
Web of Science PubMed FullText FullText_MUG

 

Issels, RD; Lindner, LH; Verweij, J; Wust, P; Reichardt, P; Schem, BC; Abdel-Rahman, S; Daugaard, S; Salat, C; Wendtner, CM; Vujaskovic, Z; Wessalowski, R; Jauch, KW; Dürr, HR; Ploner, F; Baur-Melnyk, A; Mansmann, U; Hiddemann, W; Blay, JY; Hohenberger, P; for the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG); the European Society for Hyperthermic Oncology (ESHO) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Lancet Oncol. 2010; 11(6): 561-570. Doi: 10.1016/S1470-2045(10)70071-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Hofmann, UB; Wobser, M; Kneitz, H; Kleine, P; Becker, JC; Brocker, EB; Ugurel, S Major response to paclitaxel combined with irradiation as second-line therapy in metastatic angiosarcoma of the face and scalp.
Br J Dermatol. 2009; 160(2):456-458 Doi: 10.1111/j.1365-2133.2008.08968.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Rhomberg, W; Wink, A; Pokrajac, B; Eiter, H; Hackl, A; Pakisch, B; Ginestet, A; Lukas, P; Potter, R Treatment of vascular soft tissue sarcomas with razoxane, vindesine, and radiation.
Int J Radiat Oncol Biol Phys. 2009; 74(1):187-191 Doi: 10.1016/j.ijrobp.2008.06.1492
Web of Science PubMed FullText FullText_MUG

 

2008

Benesch, M; Windelberg, M; Sauseng, W; Witt, V; Fleischhack, G; Lackner, H; Gadner, H; Bode, U; Urban, C Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors.
Ann Oncol. 2008; 19(4): 807-813. Doi: 10.1093/annonc/mdm510 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Ugurel, S Targeted therapy of dermatofibrosarcoma with imatinib.
J Dtsch Dermatol Ges. 2007; 5(3):261-261 Doi: 10.1111/j.1610-0387.2007.07009.x
PubMed FullText FullText_MUG

 

2006

Gattenlohner, S; Marx, A; Markfort, B; Pscherer, S; Landmeier, S; Juergens, H; Muller-Hermelink, HK; Matthews, I; Beeson, D; Vincent, A; Rossig, C Rhabdomyosarcoma lysis by T cells expressing a human autoantibody-based chimeric receptor targeting the fetal acetylcholine receptor.
Cancer Res. 2006; 66(1):24-28 Doi: 10.1158/0008-5472.CAN-05-0542 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Strenger, V; Lackner, H; Dornbusch, HJ; Beham-Schmid, C; Urban, C Images in haematology. Cervical mass after cytotoxic chemotherapy, secondary malignancy or epiphenomenon?
Br J Haematol. 2006; 135(1):1-1 Doi: 10.1111/j.1365-2141.2006.06189.x (- Case Report)
PubMed FullText FullText_MUG

 

2002

Kotz, R; Dominkus, M; Zettl, T; Ritschl, P; Windhager, R; Gadner, H; Zielinski, C; Salzer-Kuntschik, M Advances in bone tumour treatment in 30 years with respect to survival and limb salvage. A single institution experience.
Int Orthop. 2002; 26(4):197-202 Doi: 10.1007/s00264-002-0365-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Sluga, M; Windhager, R; Pfeiffer, M; Ofner, P; Lang, S; Dominkus, M; Nehrer, S; Zoubek, A; Kotz, R Osteosarcoma and Ewing's sarcoma--The most frequent malignant bone tumors in children--therapy and outcome
Z Orthop Ihre Grenzgeb. 2002; 140(6):652-655 Doi: 10.1055/s-2002-36040
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Bauernhofer, T; Stöger, H; Kasparek, AK; Ploner, F; Kuss, I; Pieber, TR; Kotz, R; Samonigg, H Combined treatment of metastatic osteosarcoma of the spine.
Oncology. 1999; 57(4):265-268 Doi: 10.1159/000012058 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Gunia, S; Hussein, S; Radu, DL; Pütz, KM; Breyer, R; Hecker, H; Samii, M; Walter, GF; Stan, AC CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth of 9L gliosarcoma.
Clin Exp Metastasis. 1999; 17(3):221-230 Doi: 10.1023/A:1006699203287
Web of Science PubMed FullText FullText_MUG

 

Sluga, M; Windhager, R; Lang, S; Heinzl, H; Bielack, S; Kotz, R Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma.
Clin Orthop Relat Res. 1999; 40(358):120-127 Doi: 10.1097/00003086-199901000-00015
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Lackner, H; Urban, C Successful treatment of orbital rhabdomyosarcoma in two infants using chemotherapy alone.
Med Pediatr Oncol. 1997; 28(6):463-464 Doi: 10.1002%2F%28SICI%291096-911X%28199706%2928%3A6%3C463%3A%3AAID-MPO14%3E3.0.CO%3B2-A (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

1984

Fritsch, G; Urban, C Transient encephalopathy during the late course of treatment with high-dose methotrexate.
Cancer. 1984; 53(9):1849-1851 Doi: 10.1002/1097-0142(19840501)53:9<1849::AID-CNCR2820530909>3.0.CO;2-6 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1982

Rosen, G; Caparros, B; Huvos, AG; Kosloff, C; Nirenberg, A; Cacavio, A; Marcove, RC; Lane, JM; Mehta, B; Urban, C Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
Cancer. 1982; 49(6):1221-1230 Doi: 10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Urban, C; Rosen, G New therapeutic results in osteosarcoma
WIEN MED WOCHENSCHR. 1982; 132(13-14): 335-341.
Web of Science PubMed

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum